Dragin, N., Le Panse, R., Berrih-Aknin, S. :
Predisposition aux pathologies auto-immmunes – Les hommes ne manquent pas << d'Aire >>
Med Sci (Paris), 2017 ; 33 (2) : 169-175
Publications (1184)
Guiraud, S., Migeon, T., Ferry, A., Chen, Z., Ouchelouche, S., Verpont, M. C., Sado, Y., Allamand, V., Ronco, P., Plaisier, E. :
HANAC Col4a1 Mutation in Mice Leads to Skeletal Muscle Alterations due to a Primary Vascular Defect Am J Pathol, 2017 ; 187 (3) : 505-516
HANAC Col4a1 Mutation in Mice Leads to Skeletal Muscle Alterations due to a Primary Vascular Defect Am J Pathol, 2017 ; 187 (3) : 505-516
Preusse, C., Allenbach, Y., Hoffmann, O., Goebel, H. H., Pehl, D., Radke, J., Doeser, A., Schneider, U., Alten, R. H., Kallinich, T., Benveniste, O., von Moers, A., Schoser, B., Schara, U., Stenzel, W. :
Differential roles of hypoxia and innate immunity in juvenile and adult dermatomyositis Acta Neuropathol Commun, 2016 ; 4 (1) : 45
Differential roles of hypoxia and innate immunity in juvenile and adult dermatomyositis Acta Neuropathol Commun, 2016 ; 4 (1) : 45
Eymard, B., Camdessanche, J. P. :
Foreword Rev Neurol (Paris), 2016 ; 172 (10) : 537-538
Foreword Rev Neurol (Paris), 2016 ; 172 (10) : 537-538
Beyer, S., Pontis, J., Schirwis, E., Battisti, V., Rudolf, A., Le Grand, F., Ait-Si-Ali, S. :
Canonical Wnt signalling regulates nuclear export of Setdb1 during skeletal muscle terminal differentiation. Erratum: Canonical Wnt signalling regulates nuclear export of Setdb1 during skeletal muscle terminal differentiation. [Cell Discov. 2016] Cell Discov, 2016 ; 2 : 16037
Canonical Wnt signalling regulates nuclear export of Setdb1 during skeletal muscle terminal differentiation. Erratum: Canonical Wnt signalling regulates nuclear export of Setdb1 during skeletal muscle terminal differentiation. [Cell Discov. 2016] Cell Discov, 2016 ; 2 : 16037
Stergiou, C., Lazaridis, K., Zouvelou, V., Tzartos, J., Mantegazza, R., Antozzi, C., Andreetta, F., Evoli, A., Deymeer, F., Saruhan-Direskeneli, G., Durmus, H., Brenner, T., Vaknin, A., Berrih-Aknin, S., Behin, A., Sharshar, T., De Baets, M., Losen, M., Martinez-Martinez, P., Kleopa, K. A., Zamba-Papanicolaou, E., Kyriakides, T., Kostera-Pruszczyk, A., Szczudlik, P., Szyluk, B., Lavrnic, D., Basta, I., Peric, S., Tallaksen, C., Maniaol, A., Gilhus, N. E., Casasnovas Pons, C., Pitha, J., Jakubikova, M., Hanisch, F., Bogomolovas, J., Labeit, D., Labeit, S., Tzartos, S. J. :
Titin antibodies in “seronegative” myasthenia gravis – A new role for an old antigen J Neuroimmunol, 2016 ; 292 : 108-15
Titin antibodies in “seronegative” myasthenia gravis – A new role for an old antigen J Neuroimmunol, 2016 ; 292 : 108-15
Alameddine, H. S., Morgan, J. E. :
Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Inflammation and Fibrosis of Skeletal Muscles J Neuromuscul Dis, 2016 ; 3 (4) : 455-473
Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Inflammation and Fibrosis of Skeletal Muscles J Neuromuscul Dis, 2016 ; 3 (4) : 455-473
Ziat, E., Mamchaoui, K., Beuvin, M., Nelson, I., Azibani, F., Spuler, S., Bonne, G., Bertrand, A. T. :
FHL1B Interacts with Lamin A/C and Emerin at the Nuclear Lamina and is Misregulated in Emery-Dreifuss Muscular Dystrophy J Neuromuscul Dis, 2016 ; 3 (4) : 497-510
FHL1B Interacts with Lamin A/C and Emerin at the Nuclear Lamina and is Misregulated in Emery-Dreifuss Muscular Dystrophy J Neuromuscul Dis, 2016 ; 3 (4) : 497-510
Weiss, J. M., Robinet, M., Aricha, R., Cufi, P., Villeret, B., Lantner, F., Shachar, I., Fuchs, S., Souroujon, M. C., Berrih-Aknin, S., Le Panse, R. :
Novel CXCL13 transgenic mouse: inflammation drives pathogenic effect of CXCL13 in experimental myasthenia gravis Oncotarget, 2016 ; 7 (7) : 7550-62
Novel CXCL13 transgenic mouse: inflammation drives pathogenic effect of CXCL13 in experimental myasthenia gravis Oncotarget, 2016 ; 7 (7) : 7550-62
Roy, P., Rau, F., Ochala, J., Messeant, J., Fraysse, B., Laine, J., Agbulut, O., Butler-Browne, G., Furling, D., Ferry, A. :
Dystrophin restoration therapy improves both the reduced excitability and the force drop induced by lengthening contractions in dystrophic mdx skeletal muscle Skelet Muscle, 2016 ; 6 (23) : 1-17
Dystrophin restoration therapy improves both the reduced excitability and the force drop induced by lengthening contractions in dystrophic mdx skeletal muscle Skelet Muscle, 2016 ; 6 (23) : 1-17
